Androgen Receptor Inhibition Suppresses Anti-Tumor Neutrophil Response against Bone Metastatic Prostate Cancer via Regulation of TβRI Expression

Using patient peripheral blood polymorphonuclear neutrophils, scientists identified that prostate cancer progression dictated polymorphonuclear neutrophils cell surface markers and gene expression, but not cytotoxicity against prostate cancer.